Amplitude Vascular Systems

Series-B
avspulse.com Biotech & Healthcare Boston, United States
Total Funding Undisclosed
Latest Round Undisclosed Series-B
Last Announced Feb 5, 2025
Investors 2 Backers
Decision Makers 6 Available

About Amplitude Vascular Systems

This Is IVL Amplified.® Calcified arterial disease is a significant challenge affecting patients around the world — one with limited treatment options. But we're developing a groundbreaking way to combat this dangerous disease: Pulse IVL™. Different Deliverable Efficient Easy to Use Let's Talk.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Boston, United States
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website avspulse.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @AVS_PIVL (25 followers)
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised undisclosed · Series-B

    fundraisingfox.com

  2. Capital Raise

    Raised undisclosed · Series-B

    fundraisingfox.com

Investors & Backers

2
BioStar Capital
CUE Growth Partners

Funding History

2 Rounds
Series-B equity · Feb 5, 2025
Series-B equity · Jan 6, 2023

Founders & Leadership

1

Robert Chisena

Co-Founder & Chief Technology Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts